Immunoglobulin antibody panels
Antibodies . | No. of patients . |
|---|---|
| Single antibody panels | |
| Anti-κ-FITC, anti-λ-PE, anti-CD20-PerCP* | 10 |
| Anti-κ-FITC, anti-λ-PE, anti-CD19-PC5† | 3 |
| Anti-κ-FITC, anti-λ-PE, anti-CD3-PerCP | 1 |
| Anti-κ-FITC, anti-λ-PE, anti-CD45-PerCP | 3 |
| Double antibody panels | |
| Anti-κ-FITC, anti-CD22-PE, anti-CD20-PerCP‡ | 14 |
| Anti-λ-FITC, anti-CD22-PE, anti-CD20-PerCP‡ | |
| Anti-κ-FITC, anti-CD22-PE, anti-CD45-PerCP, anti-CD19-APC | 5 |
| Anti-λ-FITC, anti-CD22-PE, anti-CD45-PerCP, anti-CD19-APC | |
| Anti-κ-FITC, anti-CD10-PE, anti-CD20-PerCP, anti-CD45-APC | 1 |
| Anti-λ-FITC, anti-CD10-PE, anti-CD20-PerCP, anti-CD45-APC | |
| Anti-κ-FITC, anti-CD22-PE, anti-CD45-PerCP, anti-CD10-APC | 1 |
| Anti-λ-FITC, anti-CD22-PE, anti-CD45-PerCP, anti-CD10-APC | |
| Anti-κ-FITC, anti-CD22-PE, anti-CD19-PE, anti-CD45-PerCP, anti-CD14-APC | 3 |
| Anti-λ-FITC, anti-CD22-PE, anti-CD19-PE, anti-CD45-PerCP, anti-CD14-APC | |
| Anti-κ-FITC, anti-CD38-PE, anti-CD20-PerCP | 1 |
| Anti-λ-FITC, anti-CD38-PE, anti-CD20-PerCP | |
| Triple antibody panels | |
| Anti-κ-FITC, anti-λ-PE, anti-CD19-PC5, anti-CD10-APC | 2 |
| Anti-κ-FITC, anti-CD22-PE, anti-CD20-PerCP, anti-CD10-APC | |
| Anti-λ-FITC, anti-CD22-PE, anti-CD20-PerCP, anti-CD10-APC |
Antibodies . | No. of patients . |
|---|---|
| Single antibody panels | |
| Anti-κ-FITC, anti-λ-PE, anti-CD20-PerCP* | 10 |
| Anti-κ-FITC, anti-λ-PE, anti-CD19-PC5† | 3 |
| Anti-κ-FITC, anti-λ-PE, anti-CD3-PerCP | 1 |
| Anti-κ-FITC, anti-λ-PE, anti-CD45-PerCP | 3 |
| Double antibody panels | |
| Anti-κ-FITC, anti-CD22-PE, anti-CD20-PerCP‡ | 14 |
| Anti-λ-FITC, anti-CD22-PE, anti-CD20-PerCP‡ | |
| Anti-κ-FITC, anti-CD22-PE, anti-CD45-PerCP, anti-CD19-APC | 5 |
| Anti-λ-FITC, anti-CD22-PE, anti-CD45-PerCP, anti-CD19-APC | |
| Anti-κ-FITC, anti-CD10-PE, anti-CD20-PerCP, anti-CD45-APC | 1 |
| Anti-λ-FITC, anti-CD10-PE, anti-CD20-PerCP, anti-CD45-APC | |
| Anti-κ-FITC, anti-CD22-PE, anti-CD45-PerCP, anti-CD10-APC | 1 |
| Anti-λ-FITC, anti-CD22-PE, anti-CD45-PerCP, anti-CD10-APC | |
| Anti-κ-FITC, anti-CD22-PE, anti-CD19-PE, anti-CD45-PerCP, anti-CD14-APC | 3 |
| Anti-λ-FITC, anti-CD22-PE, anti-CD19-PE, anti-CD45-PerCP, anti-CD14-APC | |
| Anti-κ-FITC, anti-CD38-PE, anti-CD20-PerCP | 1 |
| Anti-λ-FITC, anti-CD38-PE, anti-CD20-PerCP | |
| Triple antibody panels | |
| Anti-κ-FITC, anti-λ-PE, anti-CD19-PC5, anti-CD10-APC | 2 |
| Anti-κ-FITC, anti-CD22-PE, anti-CD20-PerCP, anti-CD10-APC | |
| Anti-λ-FITC, anti-CD22-PE, anti-CD20-PerCP, anti-CD10-APC |
Additional tube with antibody to detect T and natural killer (NK) cells was added in 4 cases but did not affect diagnosis.
FITC indicates fluorescein isothiocyanate; PE, phycoerythrin; PerCP, peridinin chlorophyll protein; APC, allophycoerythrin.
Had a fourth APC-conjugated antibody in some cases: * 7 cases no fourth antibody, 1 case anti-CD19-APC, 1 case anti-CD10-APC, 1 case anti-CD45-APC; † 1 case no fourth antibody, 1 case anti-CD10-APC, 1 case anti-CD45-APC; ‡ 11 cases no fourth antibody, 2 cases anti-CD19-APC, 1 case anti-CD45-APC.